Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • After demonstrating 57% remission rate, Israeli immunotherapy licensed by US firm
04 Jan

After demonstrating 57% remission rate, Israeli immunotherapy licensed by US firm

By admin 0 Comments

Some 85% of patients improved after taking new therapy developed by Bar Ilan and Hadassah; method involves adding artificial molecule to T-cells

Details
Vote up!
Vote down!

Points: -19

Category: 
Tech Israel
cancer
immunotherapy
Bar-Ilan University
medical care
T cells
  • Log in or register to post comments

Author

anon

admin

Hot

  • Top Israeli Rabbis Declare Time to Say Hallel, Drop Tachanun After Historic U.S. Airstrikes on Iran
  • Rudy Giuliani: Trump ‘Saved The World From A Maniac’
  • 1st Ceasefire Violation: Iran Fires Missile At Northern Israel

User login

  • Create new account
  • Request new password

Recent comments

No comments available.